https://scholars.lib.ntu.edu.tw/handle/123456789/525102
標題: | A Review of Biomarkers for Alzheimer’s Disease in Down Syndrome | 作者: | NI-CHUNG LEE YIN-HSIU CHIEN WUH-LIANG HWU |
公開日期: | 2017 | 出版社: | Springer Healthcare | 卷: | 6 | 起(迄)頁: | 69-81 | 來源出版物: | Neurology and Therapy | 摘要: | Down syndrome (Trisomy 21; DS) is a unique disease known to be associated with early-onset Alzheimer’s disease (AD). The initial presentation of AD in DS is usually difficult to recognize, owing to the underlying intellectual disabilities. Using biomarkers as a prediction tool for detecting AD in at-risk people with DS may benefit patient care. The objective of this review is to discuss the utility of biomarkers in DS on the basis of the pathophysiology of the disease and to provide an update on recent studies in this field. Only through the comprehensive assessment of clinical symptoms, imaging studies, and biomarker analyses can people with DS who are at risk for AD be diagnosed early. Studies for biomarkers of AD in DS have focused on the common pathophysiology of AD in people with DS and in the general population. The most extensively studied biomarkers are amyloid and tau. Owing to the nature of amyloid precursor protein overproduction in DS, the baseline β-amyloid (Aβ) plasma levels are higher than those in controls. Hence, the changes in Aβ are considered to be a predictive marker for AD in DS. In addition, other markers related to telomere length, neuroinflammation, and methylation have been investigated for their correlation with AD progression. Future studies including different ethnic groups may be helpful to collect sufficient data to monitor drug safety and efficacy, stratify patients at risk for AD, and quantify the benefit of treatment. ? 2017, The Author(s). |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85025170358&doi=10.1007%2fs40120-017-0071-y&partnerID=40&md5=0518bb0901ed71e778efbe48b3699b16 https://scholars.lib.ntu.edu.tw/handle/123456789/525102 |
ISSN: | 2193-8253 | DOI: | 10.1007/s40120-017-0071-y | SDG/關鍵字: | adenosylhomocysteinase; amyloid; amyloid beta protein; amyloid beta protein[1-40]; amyloid beta protein[1-42]; amyloid beta protein[25-35]; biological marker; collagenase 3; gelatinase B; interleukin 10; interleukin 6; interleukin 8; interstitial collagenase; tau protein; tumor necrosis factor; Alzheimer disease; Behavior Dementia Questionnaire; cognitive defect; Dementia Questionnaire for Mentally Retarded Persons; Dementia Scale for Down Syndrome; Dementia Screening Questionnaire for Individuals with Intellectual Disabilities; Down syndrome; genotype; human; nervous system inflammation; pathophysiology; positron emission tomography; priority journal; Rapid Assessment for Developmental Disabilities; Review; scoring system |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。